UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 205

Sortiert nach

Cell-based therapeutic strategies for multiple sclerosis

Brain (London, England : 1878), 2017-11, Vol.140 (11), p.2776-2796

2017

Volltextzugriff (PDF)

Can reproductive health services be used to screen for sexual and gender-based violence in post-conflict Northern Uganda? – a pilot study

African health sciences, 2024-04, Vol.24 (1), p.104-111

2024

Volltextzugriff (PDF)

The diagnosis of primary central nervous system vasculitis

Practical neurology, 2020-04, Vol.20 (2), p.109

2020

Volltextzugriff (PDF)

Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases

The Lancet (British edition), 2013-10, Vol.382 (9899), p.1204-1213

2013

Volltextzugriff (PDF)

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia

Nature communications, 2022-08, Vol.13 (1), p.4655-8, Article 4655

2022

Volltextzugriff (PDF)

Primary progressive multiple sclerosis: progress and challenges

Journal of Neurology, Neurosurgery and Psychiatry, 2013-10, Vol.84 (10), p.1100-1106

2013

Volltextzugriff (PDF)

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Lancet neurology, 2017-04, Vol.16 (4), p.271-281

2017

Volltextzugriff (PDF)

Cell Therapy for Multiple Sclerosis

CNS drugs, 2017-06, Vol.31 (6), p.453-469

2017

Volltextzugriff (PDF)

Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection

Multiple sclerosis, 2022-07, Vol.28 (8), p.1179-1188

2022

Volltextzugriff (PDF)

The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies

Stem cells translational medicine, 2024-03, Vol.13 (3), p.219-229

2024

Volltextzugriff (PDF)

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

Blood, 2016-12, Vol.128 (24), p.2824-2833

2016

Volltextzugriff (PDF)

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells

Acta neuropathologica, 2018-06, Vol.135 (6), p.907-921

2018

Volltextzugriff (PDF)

The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function

Journal of neuroinflammation, 2012-04, Vol.9 (1), p.63-63, Article 561

2012

Volltextzugriff (PDF)

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum

Brain pathology (Zurich, Switzerland), 2015-11, Vol.25 (6), p.692-700

2015

Volltextzugriff (PDF)

CNS involvement in systemic vasculitides

Journal of the neurological sciences, 2021-05, Vol.424, p.117423-117423, Article 117423

Scolding, Neil

2021

Volltextzugriff (PDF)

Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Neurology, 2018-05, Vol.90 (18), p.819

2018

Volltextzugriff (PDF)

Nodding syndrome: a concise review

Brain communications, 2020-01, Vol.2 (1), p.fcaa037-fcaa037

2020

Volltextzugriff (PDF)

Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis

Journal of neuropathology and experimental neurology, 2010-11, Vol.69 (11), p.1087-1095

2010

Volltextzugriff (PDF)

Percutaneous Endoscopic Gastrostomy Tube Insertion in Neurodegenerative Disease: A Retrospective Study and Literature Review

Clinical Endoscopy, 2017, 50(3), , pp.270-278

2017

Volltextzugriff (PDF)

Central nervous system vasculitis

Seminars in immunopathology, 2009-11, Vol.31 (4), p.527-536

Scolding, Neil J.

2009

Volltextzugriff (PDF)

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor

Brain research, 2012-01, Vol.1431 (11), p.86-96

2012

Volltextzugriff (PDF)

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis

Cytotherapy (Oxford, England), 2018-01, Vol.20 (1), p.21-28

2018

Volltextzugriff (PDF)

Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival

Journal of neurochemistry, 2010-09, Vol.114 (6), p.1569-1580

2010

Volltextzugriff (PDF)

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

Multiple sclerosis, 2018-06, Vol.24 (7), p.919-931

2018

Volltextzugriff (PDF)

Neurology and what?

Brain (London, England : 1878), 2020-05, Vol.143 (5), p.1613-1615

Scolding, Neil

2020

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cell-based therapeutic strategies for multiple sclerosis

Can reproductive health services be used to screen for sexual and gender-based violence in post-conflict Northern Uganda? – a pilot study

The diagnosis of primary central nervous system vasculitis

Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia

Primary progressive multiple sclerosis: progress and challenges

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Cell Therapy for Multiple Sclerosis

Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection

The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells

The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum

CNS involvement in systemic vasculitides

Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Nodding syndrome: a concise review

Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis

Percutaneous Endoscopic Gastrostomy Tube Insertion in Neurodegenerative Disease: A Retrospective Study and Literature Review

Central nervous system vasculitis

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis

Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

Neurology and what?

Suchergebnisse filtern